Role of Greyscale and Power Doppler Sonography in Therapy Monitoring in Early Rheumatoid Arthritis (RA)

Rheumatoid Arthritis Clinical Trial

Official title:

Therapy Monitoring in Early Rheumatoid Arthritis: The Role of Greyscale and Power Doppler Sonography A Prospective Study Of 20 Egyptian Rheumatoid Arthritis Patients

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT00854243
• Other study ID #: RA1
• Status: Not yet recruiting
• Phase: N/A
• First received: March 2, 2009
• Last updated: March 2, 2009
• Start date: April 2009
• Est. completion date: April 2010

Study information

• Verified date: March 2009
• Source: Cairo University
• Contact: n/a
• Is FDA regulated: No
• Health authority: Egypt: Ministry of Health and Population
• Study type: Observational

Clinical Trial Summary

The purpose of this study is to evaluate the role of musculoskeletal ultrasound and power Doppler in early therapy monitoring of rheumatoid arthritis patients.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 20
• Est. completion date: April 2010
• Est. primary completion date: April 2010
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years to 50 Years

Eligibility

Inclusion Criteria:

• Adults: age at disease onset >18 years and < 50 years

• Disease duration < 3 month

• Fulfilling ARA criteria for classification of RA

• DMARD naive

Exclusion Criteria:

• Age at diagnosis < 18 years

• Disease duration > 3 month

• Previous use of DMARDS

• Previous use of biologics

Study Design

Time Perspective: Prospective

Related Conditions & MeSH terms

• Arthritis
• Arthritis, Rheumatoid
• Rheumatoid Arthritis

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Cairo University